BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.84B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
NVIDIA
NVDA
|
+$1.94B |
| 4 |
Amazon
AMZN
|
+$1.5B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.61B |
| 2 |
Merck
MRK
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$309M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$227M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.57% |
| 2 | Consumer Discretionary | 8.06% |
| 3 | Financials | 7.49% |
| 4 | Healthcare | 6.58% |
| 5 | Communication Services | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $4.33M | ﹤0.01% |
86,960
+22,890
| +36% | +$1.05M |
|
2052
Gildan
GIL
$10.5B
| $4.33M | ﹤0.01% |
69,269
-53,308
| -43% | -$3.17M |
|
2053
PUT
ACM Research
ACMR
$5.6B
| $4.32M | ﹤0.01% |
1,096
| – | – |
|
|
QQXL
2054
ProShares Ultra QQQ Top 30
QQXL
$5.64M
| $4.32M | ﹤0.01% |
100,000
| – | – |
|
2055
Willis Lease Finance
WLFC
$1.2B
| $4.31M | ﹤0.01% |
95,391
+8,784
| +10% | +$379K |
|
2056
CALL
Norfolk Southern
NSC
$75.1B
| $4.3M | ﹤0.01% |
149
| – | – |
|
2057
Morningstar
MORN
$7.78B
| $4.29M | ﹤0.01% |
19,761
+2,977
| +18% | +$645K |
|
2058
Blue Owl Capital
OWL
$19.1B
| $4.28M | ﹤0.01% |
286,511
+80,527
| +39% | +$1.26M |
|
|
SBXE.U
2059
SilverBox Corp V Units
SBXE.U
| $4.27M | ﹤0.01% |
+424,449
| New | +$4.28M |
|
2060
Zions Bancorporation
ZION
$10.5B
| $4.27M | ﹤0.01% |
72,957
-37,647
| -34% | -$2.05M |
|
|
SCHR
2061
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $4.26M | ﹤0.01% |
170,000
+109,700
| +182% | +$2.76M |
|
|
MAGN
2062
Magnera Corp
MAGN
$444M
| $4.24M | ﹤0.01% |
279,930
+224,846
| +408% | +$2.61M |
|
2063
Trinity Industries
TRN
$2.36B
| $4.23M | ﹤0.01% |
160,133
-25,770
| -14% | -$701K |
|
2064
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
| $4.23M | ﹤0.01% |
134,644
-174,750
| -56% | -$5.5M |
|
|
DAWN
2065
DELISTED
Day One Biopharmaceuticals
DAWN
| $4.22M | ﹤0.01% |
453,311
+185,023
| +69% | +$1.55M |
|
2066
nCino
NCNO
$2.28B
| $4.22M | ﹤0.01% |
164,756
-17,521
| -10% | -$445K |
|
2067
iShares MSCI Emerging Markets Asia ETF
EEMA
$870M
| $4.22M | ﹤0.01% |
44,900
-3,800
| -8% | -$355K |
|
|
ECG
2068
Everus Construction Group
ECG
$7.2B
| $4.21M | ﹤0.01% |
49,198
+37,194
| +310% | +$3.33M |
|
2069
Xenon Pharmaceuticals
XENE
$6.03B
| $4.19M | ﹤0.01% |
93,462
-65,776
| -41% | -$2.76M |
|
|
PSKY
2070
PUT
Paramount Skydance Corp
PSKY
$11.4B
| $4.19M | ﹤0.01% |
3,126
-966
| -24% | -$15.1K |
|
2071
PUT
Union Pacific
UNP
$174B
| $4.19M | ﹤0.01% |
181
-115
| -39% | -$26.3K |
|
2072
NatWest
NWG
$75.9B
| $4.19M | ﹤0.01% |
239,182
+146,885
| +159% | +$2.33M |
|
2073
CALL
Sherwin-Williams
SHW
$87.2B
| $4.18M | ﹤0.01% |
129
-75
| -37% | -$25.1K |
|
2074
PUT
Zoetis
ZTS
$30.5B
| $4.18M | ﹤0.01% |
332
+179
| +117% | +$23.3K |
|
2075
CALL
Vertex Pharmaceuticals
VRTX
$128B
| $4.17M | ﹤0.01% |
92
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q4 2025 Portfolio in Review
As of Q4 2025, BNP Paribas Financial Markets held 6,035 positions worth $221B, up 18% from $187B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $25.1B of net new capital in Q4 2025, opening 491 new positions and adding to 2,632 existing holdings. Its largest new stake was Iris Energy: 4,201,138 shares worth $159M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.61B trimmed.
- BNP Paribas Financial Markets's largest Q4 2025 buy was Iris Energy: 4,201,138 shares worth $159M.
- BNP Paribas Financial Markets added most to Microsoft in Q4 2025, an estimated $2.84B increase.
- BNP Paribas Financial Markets's biggest Q4 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.61B.
- BNP Paribas Financial Markets fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $41M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $221B portfolio in Q4 2025.
- BNP Paribas Financial Markets opened 491 new positions and closed 305 in Q4 2025.
- BNP Paribas Financial Markets's portfolio value rose 18% quarter-over-quarter to $221B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.